Cleveland Clinic Diabetes and the Heart: Prevention and Management of Diabetes and its Cardiovascular Complications
Learn how to recognize the important relationship between diabetes and cardiovascular disease including understanding the current guidelines for hypertension and peripheral arterial disease management, the controversy over cardiovascular effects of weight loss drugs, and why focusing on the gut may help reduce cardiovascular disease.
Discover what's new in lipid management, along with state of the science discussions of current and future treatment approaches to help reduce complications of diabetes and prevent adverse cardiovascular events.
Topics include the impact of bariatric surgery in management of diabetes, best diet and exercise interventions, implications of clinical trials including ACCORD and Look AHEAD, and current recommendations for management of hospitalized patients with diabetes.
Objectives That Keep You in the Know
- Recognize the surgical versus medical weight management options for patients.
- Discuss the impact of the diabetes-cardiometabolic syndrome on CVD.
- Compare and contrast the efficacy and side effects of current and investigational therapies for reducing CVD risk or controlling glycemia in patients with diabetes.
- Recognize and assess CV risk factors in patients with diabetes in order to initiate interventions to reduce morbidity and mortality.
- Critically review the ADA and AACE treatment recommendations and identify their application to individualized diabetes treatment plans.
- Identify CV risk factors in patients with diabetes and recognize the appropriate surgical options.
- Use current data and clinical trials to evaluate surgical options to improve cardiac function.
Who Should Attend?
This activity is designed for primary care physicians, endocrinologists, cardiologists, diabetes educators, nurses, nurse practitioners, physician assistants, dietitians, and other health care professionals who care for patients with diabetes.
About Cleveland Clinic Endocrinology and Metabolism Institute
Ranked second in the nation by U.S. News & World Report, the Endocrinology and Metabolism Institute (EMI) is committed to providing the highest quality health care for patients with diabetes, endocrine and metabolic disorders, and obesity. Our staff is dedicated to exploring ways to improve the care of these patients and to teaching the best methods for treating them.
Our institute caregivers work together to provide the finest care in the country. Over 30 staff physicians, 18 fellows, and more than 80 nurses, medical assistants, diabetes educators, secretaries, patient service representatives, coders, administrators and managers work in our Institute’s departments and centers to ensure streamlined diagnosis and treatment of our patients. The institute includes the oldest subspecialty at Cleveland Clinic, and continues a steady rise to be among the best treatment providers of diabetes and endocrine conditions in the nation.
About Joslin Diabetes Center
Joslin Diabetes Center is the world’s preeminent diabetes clinic, diabetes research center, and provider of diabetes education. Joslin is dedicated to ensuring people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure for the disease. Founded in 1898 by Elliott P. Joslin, MD. Joslin is an independent nonprofit institution affiliated with Harvard Medical School.